A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llae019 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Xiaoliang Ouyang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Plastic Surgery. Hauptthemen laut MEDLINE: CARD Signaling Adaptor Proteins, Antibodies, Monoclonal, Humanized, Guanylate Cyclase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Regional Science Foundation, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
CARD14-associated papulosquamous eruption (CAPE) is an autosomal dominant disorder characterized by early onset of symptoms, prominent facial involvement, clinical manifestations resembling both psoriasis and pityriasis rubra pilaris (PRP), family history of psoriasis or PRP and limited response to conventional topical and systemic therapies for psoriasis or PRP. Here, we describe the clinical features of a patient with CAPE and a novel mutation of CARD14.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Plastic Surgery.
- Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
- Department of Dermatology, Taiyuan Central Hospital, Taiyuan, Shanxi, People's Republic of China.
ORCID-Profile: Chunming Li
Förderung
- National Natural Science Foundation of China
- Regional Science Foundation
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Ouyang, X., Zhang, D., Wang, X., Wu, L., Xiao, Z., Zhu, Y., Yu, S., & Li, C. (2024). A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae019
Vancouver
Ouyang X, Zhang D, Wang X, Wu L, Xiao Z, Zhu Y, et al. A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae019
BibTeX
@article{Ouyang2024,
author = {Ouyang, Xiaoliang and Zhang, Deng and Wang, Xiuping and Wu, Liang and Xiao, Zhen and Zhu, Yunxia and Yu, Simin and Li, Chunming},
title = {A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llae019}
}
EUVIMED